Возраст домена | n/a |
Дата окончания | n/a |
ИКС | n/a |
Страниц в Google | n/a |
Страниц в Яндексе | n/a |
Dmoz | n/a |
Яндекс Каталог | n/a |
Alexa Traffic Rank | n/a |
Alexa Country | n/a |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
CTGATE: Clinical Trial Generalizability Assessment Toolbox – Clinical Trial Generalizability Assessment Informatics Toolbox
n/a
n/a
UTF-8
172.61 КБ
2 198
20 293 симв.
17 635 симв.
Идет сбор информации... Обновить
Идет сбор информации... Обновить
Идет сбор информации... Обновить
Внешние ссылки главной страницы ( 187 ) | |
ncbi.nlm.nih.gov/pubmed/24926156 | 24926156 |
ncbi.nlm.nih.gov/pubmed/11870014 | 11870014 |
ncbi.nlm.nih.gov/pubmed/12153370 | 12153370 |
ncbi.nlm.nih.gov/pubmed/14628985 | 14628985 |
ncbi.nlm.nih.gov/pubmed/14770052 | 14770052 |
ncbi.nlm.nih.gov/pubmed/15705630 | 15705630 |
ncbi.nlm.nih.gov/pubmed/15876909 | 15876909 |
ncbi.nlm.nih.gov/pubmed/16227797 | 16227797 |
ncbi.nlm.nih.gov/pubmed/16339480 | 16339480 |
ncbi.nlm.nih.gov/pubmed/16569712 | 16569712 |
ncbi.nlm.nih.gov/pubmed/17502778 | 17502778 |
ncbi.nlm.nih.gov/pubmed/18438906 | 18438906 |
ncbi.nlm.nih.gov/pubmed/18501096 | 18501096 |
ncbi.nlm.nih.gov/pubmed/18557666 | 18557666 |
ncbi.nlm.nih.gov/pubmed/18577549 | 18577549 |
ncbi.nlm.nih.gov/pubmed/18579319 | 18579319 |
ncbi.nlm.nih.gov/pubmed/19057955 | 19057955 |
ncbi.nlm.nih.gov/pubmed/19342462 | 19342462 |
ncbi.nlm.nih.gov/pubmed/20547574 | 20547574 |
ncbi.nlm.nih.gov/pubmed/21078225 | 21078225 |
ncbi.nlm.nih.gov/pubmed/22459203 | 22459203 |
ncbi.nlm.nih.gov/pubmed/22495990 | 22495990 |
ncbi.nlm.nih.gov/pubmed/23060323 | 23060323 |
ncbi.nlm.nih.gov/pubmed/23075287 | 23075287 |
ncbi.nlm.nih.gov/pubmed/23137143 | 23137143 |
ncbi.nlm.nih.gov/pubmed/23242482 | 23242482 |
ncbi.nlm.nih.gov/pubmed/23553373 | 23553373 |
ncbi.nlm.nih.gov/pubmed/23561233 | 23561233 |
ncbi.nlm.nih.gov/pubmed/23617533 | 23617533 |
ncbi.nlm.nih.gov/pubmed/24475060 | 24475060 |
ncbi.nlm.nih.gov/pubmed/24621557 | 24621557 |
ncbi.nlm.nih.gov/pubmed/25154011 | 25154011 |
ncbi.nlm.nih.gov/pubmed/25307417 | 25307417 |
ncbi.nlm.nih.gov/pubmed/25580674 | 25580674 |
ncbi.nlm.nih.gov/pubmed/26747392 | 26747392 |
ncbi.nlm.nih.gov/pubmed/26866293 | 26866293 |
ncbi.nlm.nih.gov/pubmed/27379465 | 27379465 |
ncbi.nlm.nih.gov/pubmed/27491758 | 27491758 |
ncbi.nlm.nih.gov/pubmed/27663386 | 27663386 |
ncbi.nlm.nih.gov/pubmed/27844227 | 27844227 |
ncbi.nlm.nih.gov/pubmed/28088058 | 28088058 |
ncbi.nlm.nih.gov/pubmed/28416124 | 28416124 |
ncbi.nlm.nih.gov/pubmed/28535275 | 28535275 |
ncbi.nlm.nih.gov/pubmed/29097612 | 29097612 |
ncbi.nlm.nih.gov/pubmed/29462814 | 29462814 |
ncbi.nlm.nih.gov/pubmed/29915956 | 29915956 |
ncbi.nlm.nih.gov/pubmed/29936654 | 29936654 |
ncbi.nlm.nih.gov/pubmed/30096830 | 30096830 |
ncbi.nlm.nih.gov/pubmed/30175440 | 30175440 |
ncbi.nlm.nih.gov/pubmed/30218805 | 30218805 |
ncbi.nlm.nih.gov/pubmed/30564154 | 30564154 |
ncbi.nlm.nih.gov/pubmed/4020412 | 4020412 |
ncbi.nlm.nih.gov/pubmed/8690832 | 8690832 |
ncbi.nlm.nih.gov/pubmed/10203081 | 10203081 |
ncbi.nlm.nih.gov/pubmed/10470428 | 10470428 |
ncbi.nlm.nih.gov/pubmed/10506672 | 10506672 |
ncbi.nlm.nih.gov/pubmed/10891631 | 10891631 |
ncbi.nlm.nih.gov/pubmed/11053697 | 11053697 |
ncbi.nlm.nih.gov/pubmed/10751862 | 10751862 |
ncbi.nlm.nih.gov/pubmed/11165726 | 11165726 |
ncbi.nlm.nih.gov/pubmed/11434951 | 11434951 |
ncbi.nlm.nih.gov/pubmed/11470387 | 11470387 |
ncbi.nlm.nih.gov/pubmed/11694202 | 11694202 |
ncbi.nlm.nih.gov/pubmed/11737343 | 11737343 |
ncbi.nlm.nih.gov/pubmed/12694711 | 12694711 |
ncbi.nlm.nih.gov/pubmed/12701762 | 12701762 |
ncbi.nlm.nih.gov/pubmed/12701935 | 12701935 |
ncbi.nlm.nih.gov/pubmed/15229421 | 15229421 |
ncbi.nlm.nih.gov/pubmed/15334432 | 15334432 |
ncbi.nlm.nih.gov/pubmed/15639683 | 15639683 |
ncbi.nlm.nih.gov/pubmed/15695979 | 15695979 |
ncbi.nlm.nih.gov/pubmed/15994721 | 15994721 |
ncbi.nlm.nih.gov/pubmed/16225942 | 16225942 |
ncbi.nlm.nih.gov/pubmed/16639738 | 16639738 |
ncbi.nlm.nih.gov/pubmed/17053977 | 17053977 |
ncbi.nlm.nih.gov/pubmed/17210880 | 17210880 |
ncbi.nlm.nih.gov/pubmed/17253599 | 17253599 |
ncbi.nlm.nih.gov/pubmed/17453387 | 17453387 |
ncbi.nlm.nih.gov/pubmed/17896305 | 17896305 |
ncbi.nlm.nih.gov/pubmed/18381709 | 18381709 |
ncbi.nlm.nih.gov/pubmed/18414962 | 18414962 |
ncbi.nlm.nih.gov/pubmed/18619799 | 18619799 |
ncbi.nlm.nih.gov/pubmed/19116800 | 19116800 |
ncbi.nlm.nih.gov/pubmed/19287330 | 19287330 |
ncbi.nlm.nih.gov/pubmed/19339358 | 19339358 |
ncbi.nlm.nih.gov/pubmed/19556533 | 19556533 |
ncbi.nlm.nih.gov/pubmed/19631869 | 19631869 |
ncbi.nlm.nih.gov/pubmed/20016742 | 20016742 |
ncbi.nlm.nih.gov/pubmed/20589596 | 20589596 |
ncbi.nlm.nih.gov/pubmed/20670761 | 20670761 |
ncbi.nlm.nih.gov/pubmed/20798576 | 20798576 |
ncbi.nlm.nih.gov/pubmed/20816030 | 20816030 |
ncbi.nlm.nih.gov/pubmed/21059426 | 21059426 |
ncbi.nlm.nih.gov/pubmed/21078416 | 21078416 |
ncbi.nlm.nih.gov/pubmed/21200334 | 21200334 |
ncbi.nlm.nih.gov/pubmed/21325996 | 21325996 |
ncbi.nlm.nih.gov/pubmed/21565848 | 21565848 |
ncbi.nlm.nih.gov/pubmed/21775882 | 21775882 |
ncbi.nlm.nih.gov/pubmed/21956723 | 21956723 |
ncbi.nlm.nih.gov/pubmed/22201327 | 22201327 |
ncbi.nlm.nih.gov/pubmed/22316122 | 22316122 |
ncbi.nlm.nih.gov/pubmed/22343692 | 22343692 |
ncbi.nlm.nih.gov/pubmed/22371462 | 22371462 |
ncbi.nlm.nih.gov/pubmed/23092978 | 23092978 |
ncbi.nlm.nih.gov/pubmed/23242479 | 23242479 |
ncbi.nlm.nih.gov/pubmed/23517248 | 23517248 |
ncbi.nlm.nih.gov/pubmed/23633161 | 23633161 |
ncbi.nlm.nih.gov/pubmed/23674318 | 23674318 |
ncbi.nlm.nih.gov/pubmed/23845385 | 23845385 |
ncbi.nlm.nih.gov/pubmed/24594552 | 24594552 |
ncbi.nlm.nih.gov/pubmed/24627277 | 24627277 |
ncbi.nlm.nih.gov/pubmed/24632781 | 24632781 |
ncbi.nlm.nih.gov/pubmed/24647464 | 24647464 |
ncbi.nlm.nih.gov/pubmed/24975869 | 24975869 |
ncbi.nlm.nih.gov/pubmed/25024761 | 25024761 |
ncbi.nlm.nih.gov/pubmed/25100338 | 25100338 |
ncbi.nlm.nih.gov/pubmed/25399847 | 25399847 |
ncbi.nlm.nih.gov/pubmed/25427819 | 25427819 |
ncbi.nlm.nih.gov/pubmed/25664626 | 25664626 |
ncbi.nlm.nih.gov/pubmed/25828873 | 25828873 |
ncbi.nlm.nih.gov/pubmed/25986472 | 25986472 |
ncbi.nlm.nih.gov/pubmed/26174313 | 26174313 |
ncbi.nlm.nih.gov/pubmed/26192398 | 26192398 |
ncbi.nlm.nih.gov/pubmed/26283667 | 26283667 |
ncbi.nlm.nih.gov/pubmed/26330533 | 26330533 |
ncbi.nlm.nih.gov/pubmed/26362666 | 26362666 |
ncbi.nlm.nih.gov/pubmed/26562046 | 26562046 |
ncbi.nlm.nih.gov/pubmed/26743093 | 26743093 |
ncbi.nlm.nih.gov/pubmed/26820188 | 26820188 |
ncbi.nlm.nih.gov/pubmed/26825855 | 26825855 |
ncbi.nlm.nih.gov/pubmed/27033859 | 27033859 |
ncbi.nlm.nih.gov/pubmed/27104965 | 27104965 |
ncbi.nlm.nih.gov/pubmed/27109827 | 27109827 |
ncbi.nlm.nih.gov/pubmed/27283295 | 27283295 |
ncbi.nlm.nih.gov/pubmed/27520290 | 27520290 |
ncbi.nlm.nih.gov/pubmed/27598694 | 27598694 |
ncbi.nlm.nih.gov/pubmed/27600407 | 27600407 |
ncbi.nlm.nih.gov/pubmed/27753599 | 27753599 |
ncbi.nlm.nih.gov/pubmed/27863344 | 27863344 |
ncbi.nlm.nih.gov/pubmed/27638094 | 27638094 |
ncbi.nlm.nih.gov/pubmed/27779514 | 27779514 |
ncbi.nlm.nih.gov/pubmed/27984524 | 27984524 |
ncbi.nlm.nih.gov/pubmed/28028598 | 28028598 |
ncbi.nlm.nih.gov/pubmed/28118923 | 28118923 |
ncbi.nlm.nih.gov/pubmed/28125858 | 28125858 |
ncbi.nlm.nih.gov/pubmed/28191694 | 28191694 |
ncbi.nlm.nih.gov/pubmed/28230450 | 28230450 |
ncbi.nlm.nih.gov/pubmed/28434933 | 28434933 |
ncbi.nlm.nih.gov/pubmed/28511033 | 28511033 |
ncbi.nlm.nih.gov/pubmed/28722466 | 28722466 |
ncbi.nlm.nih.gov/pubmed/28763313 | 28763313 |
ncbi.nlm.nih.gov/pubmed/28972695 | 28972695 |
ncbi.nlm.nih.gov/pubmed/29025047 | 29025047 |
ncbi.nlm.nih.gov/pubmed/29153885 | 29153885 |
ncbi.nlm.nih.gov/pubmed/29230192 | 29230192 |
ncbi.nlm.nih.gov/pubmed/29241487 | 29241487 |
ncbi.nlm.nih.gov/pubmed/28963367 | 28963367 |
ncbi.nlm.nih.gov/pubmed/29020193 | 29020193 |
ncbi.nlm.nih.gov/pubmed/29097339 | 29097339 |
ncbi.nlm.nih.gov/pubmed/29288137 | 29288137 |
ncbi.nlm.nih.gov/pubmed/29426695 | 29426695 |
ncbi.nlm.nih.gov/pubmed/29464791 | 29464791 |
ncbi.nlm.nih.gov/pubmed/29569403 | 29569403 |
ncbi.nlm.nih.gov/pubmed/29693361 | 29693361 |
ncbi.nlm.nih.gov/pubmed/29701877 | 29701877 |
ncbi.nlm.nih.gov/pubmed/29884343 | 29884343 |
ncbi.nlm.nih.gov/pubmed/29895587 | 29895587 |
ncbi.nlm.nih.gov/pubmed/29944476 | 29944476 |
ncbi.nlm.nih.gov/pubmed/30001984 | 30001984 |
ncbi.nlm.nih.gov/pubmed/30094623 | 30094623 |
ncbi.nlm.nih.gov/pubmed/30189998 | 30189998 |
ncbi.nlm.nih.gov/pubmed/30221183 | 30221183 |
ncbi.nlm.nih.gov/pubmed/30373488 | 30373488 |
ncbi.nlm.nih.gov/pubmed/30415786 | 30415786 |
ncbi.nlm.nih.gov/pubmed/30466715 | 30466715 |
ncbi.nlm.nih.gov/pubmed/30477321 | 30477321 |
ncbi.nlm.nih.gov/pubmed/30555215 | 30555215 |
ncbi.nlm.nih.gov/pubmed/30685675 | 30685675 |
ncbi.nlm.nih.gov/pubmed/30252687 | 30252687 |
ncbi.nlm.nih.gov/pubmed/30312378 | 30312378 |
ncbi.nlm.nih.gov/pubmed/30420256 | 30420256 |
ncbi.nlm.nih.gov/pubmed/30673974 | 30673974 |
ncbi.nlm.nih.gov/pubmed/30714309 | 30714309 |
ncbi.nlm.nih.gov/pubmed/30746585 | 30746585 |
ncbi.nlm.nih.gov/pubmed/30819552 | 30819552 |
ncbi.nlm.nih.gov/pubmed/30822358 | 30822358 |
ncbi.nlm.nih.gov/pubmed/30846172 | 30846172 |
Внутренние ссылки главной страницы ( 199 ) | |
# | - |
ctgate.cci.fsu.edu/ | CTGATE: Clinical Trial Generalizability Assessment Toolbox |
ctgate.cci.fsu.edu/?page_id=826 | Tutorials |
ctgate.cci.fsu.edu/?page_id=834 | About CTGate |
ctgate.cci.fsu.edu/?page_id=840 | Related Publication |
ctgate.cci.fsu.edu/?page_id=843 | Team Members |
ctgate.cci.fsu.edu/?page_id=1030 | Contact Us |
ctgate.cci.fsu.edu/?page_id=219 | The use of propensity scores to assess the generalizability of results from randomized trials |
ctgate.cci.fsu.edu/tutorials/pspsbm.html | Propensity score weighting/matching |
ctgate.cci.fsu.edu/?page_id=220 | Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? |
ctgate.cci.fsu.edu/?page_id=221 | Representation of the elderly, women, and minorities in heart failure clinical trials |
ctgate.cci.fsu.edu/?page_id=222 | How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? |
ctgate.cci.fsu.edu/?page_id=223 | Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included... |
ctgate.cci.fsu.edu/?page_id=224 | Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria. |
ctgate.cci.fsu.edu/?page_id=225 | Effect of study criteria on recruitment and generalizability of the results. |
ctgate.cci.fsu.edu/?page_id=226 | Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protoc... |
ctgate.cci.fsu.edu/?page_id=227 | Potential consequences for recruitment, power, and external validity of requirements for additional risk factors for eligibility... |
ctgate.cci.fsu.edu/?page_id=228 | Randomized Controlled Trials: Do They Have External Validity for Patients With Multiple Comorbidities? |
ctgate.cci.fsu.edu/?page_id=229 | Relevance of exclusion criteria in antidepressant clinical trials: A replication study. |
ctgate.cci.fsu.edu/?page_id=230 | Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatme... |
ctgate.cci.fsu.edu/?page_id=231 | Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative ... |
ctgate.cci.fsu.edu/?page_id=232 | Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Su... |
ctgate.cci.fsu.edu/?page_id=233 | Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized... |
ctgate.cci.fsu.edu/?page_id=234 | Generalizability of clinical trials for alcohol dependence to community samples. |
ctgate.cci.fsu.edu/?page_id=235 | Analysis of patient selection and external validity in the Swedish contribution to the COLOR trial. |
ctgate.cci.fsu.edu/?page_id=236 | Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced su... |
ctgate.cci.fsu.edu/?page_id=237 | Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial. |
ctgate.cci.fsu.edu/?page_id=238 | The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. |
ctgate.cci.fsu.edu/?page_id=239 | Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-se... |
ctgate.cci.fsu.edu/?page_id=240 | Generalizability of clinical trial results for generalized anxiety disorder to community samples. |
ctgate.cci.fsu.edu/?page_id=241 | Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to ... |
ctgate.cci.fsu.edu/?page_id=242 | External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants... |
ctgate.cci.fsu.edu/?page_id=243 | The generalizability of psychotherapy efficacy trials in major depressive disorder: An analysis of the influence of patient sele... |
ctgate.cci.fsu.edu/?page_id=244 | Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation pati... |
ctgate.cci.fsu.edu/?page_id=245 | The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias. |
ctgate.cci.fsu.edu/?page_id=246 | Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic S... |
ctgate.cci.fsu.edu/?page_id=247 | Not-in-trial simulation I: Bridging cardiovascular risk from clinical trials to real-life conditions. |
ctgate.cci.fsu.edu/?page_id=248 | The real world mental health needs of heart failure patients are not reflected by the depression randomized controlled trial evi... |
ctgate.cci.fsu.edu/?page_id=249 | Why do GPs exclude patients from participating in research? An exploration of adherence to and divergence from trial criteria. |
ctgate.cci.fsu.edu/?page_id=250 | Are participants in pharmacological and psychotherapy treatment trials for social anxiety disorder representative of patients in... |
ctgate.cci.fsu.edu/?page_id=251 | Assessing the generalizability of randomized trial results to target populations. |
ctgate.cci.fsu.edu/?page_id=252 | Generalizability of pharmacological and psychotherapy clinical trial results for borderline personality disorder to community sa... |
ctgate.cci.fsu.edu/?page_id=253 | Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified? |
ctgate.cci.fsu.edu/?page_id=254 | Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials. |
ctgate.cci.fsu.edu/?page_id=255 | Generalizability of Pharmacologic and Psychotherapy Clinical Trial Results for Posttraumatic Stress Disorder to Community Sample... |
ctgate.cci.fsu.edu/?page_id=256 | Generalizing Treatment Effect Estimates From Sample to Population: A Case Study in the Difficulties of Finding Sufficient Data. |
ctgate.cci.fsu.edu/?page_id=257 | Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. |
ctgate.cci.fsu.edu/?page_id=258 | A novel use of the Spine Tango registry to evaluate selection bias in patient recruitment into clinical studies: an analysis of ... |
ctgate.cci.fsu.edu/?page_id=259 | Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy t... |
ctgate.cci.fsu.edu/?page_id=260 | Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guide... |
ctgate.cci.fsu.edu/?page_id=261 | Transportability of trial results using inverse odds of sampling weights. |
ctgate.cci.fsu.edu/?page_id=262 | Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder. |
ctgate.cci.fsu.edu/?page_id=263 | Generalizability of Findings from a Randomized Controlled Trial of Fish Oil Supplementation for Attenuating Posttraumatic Stress... |
ctgate.cci.fsu.edu/?page_id=264 | Generalizability of clinical trials of advanced melanoma in the real-world, population-based setting. |
ctgate.cci.fsu.edu/?page_id=265 | Eligibility of real-world patients with chemo-refractory, K-RAS wild-type, metastatic colorectal cancer for palliative intent re... |
ctgate.cci.fsu.edu/?page_id=266 | Inclusion and Exclusion Criteria of Clinical Trials for Insomnia. |
ctgate.cci.fsu.edu/?page_id=267 | Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D C... |
ctgate.cci.fsu.edu/?page_id=268 | Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Ran... |
ctgate.cci.fsu.edu/?page_id=269 | The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial |
ctgate.cci.fsu.edu/?page_id=270 | Selection bias in clinical trials. |
ctgate.cci.fsu.edu/tutorials/NHANES_T2D.html | Comparing populations in clinical studies |
ctgate.cci.fsu.edu/?page_id=271 | Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study. |
ctgate.cci.fsu.edu/?page_id=272 | Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the... |
ctgate.cci.fsu.edu/?page_id=273 | Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. |
ctgate.cci.fsu.edu/?page_id=274 | Generalizing from a controlled trial: the effects of patient preference versus randomization on the outcome of inpatient versus ... |
ctgate.cci.fsu.edu/?page_id=275 | Generalizability of project MATCH: a comparison of clients enrolled to those not enrolled in the study at one aftercare site. |
ctgate.cci.fsu.edu/?page_id=276 | Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable ... |
ctgate.cci.fsu.edu/?page_id=277 | Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factor... |
ctgate.cci.fsu.edu/?page_id=278 | The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking be... |
ctgate.cci.fsu.edu/?page_id=279 | Generalisability of clinical trials in otitis media with effusion. |
ctgate.cci.fsu.edu/?page_id=280 | Generalizability of trial results based on randomized versus nonrandomized allocation of OME infants to ventilation tubes or wat... |
ctgate.cci.fsu.edu/?page_id=281 | Generalizability of findings from a chewing tobacco cessation clinical trial. |
ctgate.cci.fsu.edu/?page_id=282 | How generalizable are the results of large randomized controlled trials of antiretroviral therapy? |
ctgate.cci.fsu.edu/?page_id=283 | External validity of a randomised clinical trial of temporomandibular disorders: analysis of the patients who refused to partici... |
ctgate.cci.fsu.edu/?page_id=284 | Representativeness of trial populations: an example from a trial of adenotonsillectomy in children. |
ctgate.cci.fsu.edu/?page_id=285 | Does clinical trial subject selection restrict the ability to generalize use and cost of health services to "real life" subjects... |
ctgate.cci.fsu.edu/?page_id=286 | Assessing clinical generalizability in sedation studies of upper GI endoscopy. |
ctgate.cci.fsu.edu/?page_id=287 | Differences between participants and nonparticipants in an exercise trial for adults with rheumatoid arthritis. |
ctgate.cci.fsu.edu/?page_id=288 | External validity of randomised controlled trials: "to whom do the results of this trial apply?". |
ctgate.cci.fsu.edu/?page_id=289 | Population characteristics in cervical cancer trials: search for external validity. |
ctgate.cci.fsu.edu/?page_id=290 | Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not... |
ctgate.cci.fsu.edu/?page_id=291 | Selection bias of elderly patients with chronic angina referred for catheterization. |
ctgate.cci.fsu.edu/?page_id=292 | Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. |
ctgate.cci.fsu.edu/?page_id=293 | Empirical evaluation of the generalizability of the sample from the Multimodal Treatment Study of ADHD. |
ctgate.cci.fsu.edu/?page_id=294 | External validity of clinical trials in acute myocardial infarction. |
ctgate.cci.fsu.edu/?page_id=295 | External validity of ST elevation myocardial infarction trials: the Zwolle studies. |
ctgate.cci.fsu.edu/?page_id=296 | To whom do the results of this trial apply?" External validity of a randomized controlled trial involving 130 patients scheduled... |
ctgate.cci.fsu.edu/?page_id=297 | Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) ra... |
ctgate.cci.fsu.edu/?page_id=298 | Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant users. |
ctgate.cci.fsu.edu/?page_id=299 | Lifetime characteristics of participants and non-participants in a smoking cessation trial: implications for external validity a... |
ctgate.cci.fsu.edu/?page_id=300 | Randomized patients in IBS research had different disease characteristics compared to eligible and recruited patients. |
ctgate.cci.fsu.edu/?page_id=301 | Characteristics of individuals with insomnia who seek treatment in a clinical setting versus those who volunteer for a randomize... |
ctgate.cci.fsu.edu/?page_id=302 | Examination of external validity in randomized controlled trials for adjuvant treatment of pancreatic adenocarcinoma. |
ctgate.cci.fsu.edu/?page_id=303 | Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. |
ctgate.cci.fsu.edu/?page_id=304 | Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack o... |
ctgate.cci.fsu.edu/?page_id=305 | Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. |
ctgate.cci.fsu.edu/?page_id=306 | Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in p... |
ctgate.cci.fsu.edu/?page_id=307 | Trials assessing parmacotherapeutic management of aggression in psychiatric patients: comparability with clinical practice. |
ctgate.cci.fsu.edu/?page_id=308 | Clinical characteristics of patients undergoing surgical ventricular reconstruction by choice and by randomization. |
ctgate.cci.fsu.edu/?page_id=309 | Patients with borderline personality disorder not participating in an RCT: are they different? |
ctgate.cci.fsu.edu/?page_id=310 | Representativeness of participants in a clinical trial for attention-deficit/hyperactivity disorder? Comparison with adults from... |
ctgate.cci.fsu.edu/?page_id=311 | Comparison of baseline characteristics, management and outcome of patients with non-ST-segment elevation acute coronary syndrome... |
ctgate.cci.fsu.edu/?page_id=312 | The generalizability of participants in Veterans Affairs Cooperative Studies Program 474, a multi-site randomized cardiac bypass... |
ctgate.cci.fsu.edu/?page_id=313 | Comparison of Characteristics and Outcomes of Patients Undergoing Saphenous Vein Graft Stenting Who Were or Were Not nrolled in ... |
ctgate.cci.fsu.edu/?page_id=314 | Age, exclusion criteria, and generalizability of randomized trials enrolling kidney transplant recipients. |
ctgate.cci.fsu.edu/?page_id=315 | Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants. |
ctgate.cci.fsu.edu/?page_id=316 | Cancer trials versus the real world in the United States. |
ctgate.cci.fsu.edu/?page_id=317 | ALS clinical trials: do enrolled patients accurately represent the ALS population? |
ctgate.cci.fsu.edu/?page_id=318 | Racial/ethnic differences in adults in randomized clinical trials of binge eating disorder. |
ctgate.cci.fsu.edu/?page_id=319 | To whom do the results of the multicenter, randomized, controlled INSECT trial (ISRCTN 24023541) apply?--assessment of external ... |
ctgate.cci.fsu.edu/?page_id=320 | Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population. |
ctgate.cci.fsu.edu/?page_id=321 | Enrollment of extremely low birth weight infants in a clinical research study may not be representative. |
ctgate.cci.fsu.edu/?page_id=322 | Sampling bias in an internet treatment trial for depression. |
ctgate.cci.fsu.edu/?page_id=323 | The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and o... |
ctgate.cci.fsu.edu/?page_id=324 | Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in T... |
ctgate.cci.fsu.edu/?page_id=325 | Generalizability in the family-to-family education program randomized waitlist-control trial. |
ctgate.cci.fsu.edu/?page_id=326 | Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? |
ctgate.cci.fsu.edu/?page_id=327 | Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS base... |
ctgate.cci.fsu.edu/?page_id=328 | Representativeness of RELAX-AHF clinical trial population in acute heart failure. |
ctgate.cci.fsu.edu/?page_id=329 | In and out, good and bad news, of generalizability of SWOG treatment trial results. |
ctgate.cci.fsu.edu/?page_id=330 | Generalizability of findings from efficacy trials for chronic depression: an analysis of eligibility criteria. |
ctgate.cci.fsu.edu/?page_id=331 | External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. |
ctgate.cci.fsu.edu/?page_id=332 | External validity of the ARISTOTLE trial in real-life atrial fibrillation patients. |
ctgate.cci.fsu.edu/?page_id=333 | A distribution-based method for assessing the differences between clinical trial target populations and patient populations in e... |
ctgate.cci.fsu.edu/?page_id=334 | Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uga... |
ctgate.cci.fsu.edu/?page_id=335 | Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antipl... |
ctgate.cci.fsu.edu/?page_id=336 | Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study |
ctgate.cci.fsu.edu/?page_id=337 | Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Can... |
ctgate.cci.fsu.edu/?page_id=338 | Predicting participation in psychiatric randomized controlled trials: Insights from the STEP-BD. |
ctgate.cci.fsu.edu/?page_id=339 | An Approach to Assess Generalizability in Comparative Effectiveness Research: A Case Study of the Whole Systems Demonstrator Clu... |
ctgate.cci.fsu.edu/?page_id=340 | Similarities and differences between patients included and excluded from a randomized clinical trial of vitamin D supplementatio... |
ctgate.cci.fsu.edu/?page_id=341 | Characteristics and Outcomes of Eligible Nonenrolled Patients in a Mechanical Ventilation Trial of Acute Respiratory Distress Sy... |
ctgate.cci.fsu.edu/?page_id=342 | Exploring threats to generalisability in a large international rehabilitation trial (AVERT). |
ctgate.cci.fsu.edu/?page_id=343 | Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World Practice. |
ctgate.cci.fsu.edu/?page_id=344 | External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA. |
ctgate.cci.fsu.edu/?page_id=345 | Generalizability of SPRINT Results to the U.S. Adult Population. |
ctgate.cci.fsu.edu/?page_id=346 | How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World? |
ctgate.cci.fsu.edu/?page_id=347 | Multivariate analysis of the population representativeness of related clinical studies. |
ctgate.cci.fsu.edu/?page_id=348 | Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinica... |
ctgate.cci.fsu.edu/tutorials/SSMD.html | Standardized mean difference (SSMD) of propensity scores |
ctgate.cci.fsu.edu/?page_id=349 | External validity of the "all-comers" design: insights from the BIOSCIENCE trial. |
ctgate.cci.fsu.edu/?page_id=350 | Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validit... |
ctgate.cci.fsu.edu/?page_id=351 | Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metas... |
ctgate.cci.fsu.edu/?page_id=352 | Baseline Characteristics and Generalizability of Participants in an Internet Smoking Cessation Randomized Trial. |
ctgate.cci.fsu.edu/?page_id=353 | Older patients are still under-represented in clinical trials of Alzheimer's disease. |
ctgate.cci.fsu.edu/?page_id=354 | Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials. |
ctgate.cci.fsu.edu/?page_id=355 | GIST 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies. |
ctgate.cci.fsu.edu/tutorials/GIST_2.0.html | GIST 2.0 |
ctgate.cci.fsu.edu/?page_id=356 | External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myoc... |
ctgate.cci.fsu.edu/?page_id=357 | Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laborator... |
ctgate.cci.fsu.edu/?page_id=358 | Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men... |
ctgate.cci.fsu.edu/?page_id=359 | Patient Eligibility for Randomized Controlled Trials in Critical Care Medicine: An International Two-Center Observational Study. |
ctgate.cci.fsu.edu/?page_id=360 | Investigating generalizability of results from a randomized controlled trial of the management of chronic widespread pain: the M... |
ctgate.cci.fsu.edu/?page_id=361 | A comparison of the MOMS trial results to a contemporaneous, single-institution, postnatal closure cohort. |
ctgate.cci.fsu.edu/?page_id=362 | Computer-aided assessment of the generalizability of clinical trial results. |
ctgate.cci.fsu.edu/?page_id=363 | Generalizability analysis for clinical trials: a simulation study. |
ctgate.cci.fsu.edu/?page_id=364 | Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Tri... |
ctgate.cci.fsu.edu/?page_id=365 | Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials. |
ctgate.cci.fsu.edu/?page_id=366 | Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Eje... |
ctgate.cci.fsu.edu/?page_id=367 | Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United St... |
ctgate.cci.fsu.edu/?page_id=368 | Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. |
ctgate.cci.fsu.edu/?page_id=369 | Generalizability of EXCEL and NOBLE results to a large registry population with unprotected left main coronary artery disease. |
ctgate.cci.fsu.edu/?page_id=370 | Testing the external validity of EORTC 30904 comparing overall survival after radical nephrectomy vs nephron sparing surgery in ... |
ctgate.cci.fsu.edu/?page_id=371 | The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0. |
ctgate.cci.fsu.edu/?page_id=372 | Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treat... |
ctgate.cci.fsu.edu/?page_id=373 | External Validity of Randomized Controlled Trials on Alzheimer's Disease: The Biases of Frailty and Biological Aging. |
ctgate.cci.fsu.edu/?page_id=374 | Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. |
ctgate.cci.fsu.edu/?page_id=375 | TREVO stent-retriever mechanical thrombectomy for acute ischemic stroke secondary to large vessel occlusion registry. |
ctgate.cci.fsu.edu/?page_id=376 | Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population. |
ctgate.cci.fsu.edu/?page_id=377 | Comparable outcomes among trial and nontrial participants in a clinical trial of antibiotics for childhood pneumonia: a retrospe... |
ctgate.cci.fsu.edu/?page_id=378 | A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial:... |
ctgate.cci.fsu.edu/?page_id=379 | Only |
ctgate.cci.fsu.edu/?page_id=380 | Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta‐ana... |
ctgate.cci.fsu.edu/?page_id=381 | Generalizability of the findings from a randomized controlled trial of a web-based substance use disorder intervention. |
ctgate.cci.fsu.edu/?page_id=382 | Generalizability of the findings from a randomized controlled trial of a web-based substance use disorder intervention. |
ctgate.cci.fsu.edu/?page_id=383 | Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 ... |
ctgate.cci.fsu.edu/?page_id=384 | Nutrition Therapy in Australia and New Zealand Intensive Care Units: An International Comparison Study. |
ctgate.cci.fsu.edu/?page_id=385 | An evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the... |
ctgate.cci.fsu.edu/?page_id=386 | Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF ... |
ctgate.cci.fsu.edu/?page_id=387 | Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial in... |
ctgate.cci.fsu.edu/?page_id=388 | Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment |
ctgate.cci.fsu.edu/?page_id=389 | Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfe... |
ctgate.cci.fsu.edu/?page_id=390 | Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus. |
ctgate.cci.fsu.edu/?page_id=391 | African American Screening and Enrollment in (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III)... |
ctgate.cci.fsu.edu/?page_id=392 | Representativeness of patients enrolled in a primary care clinical trial for heavy/problem substance use |
ctgate.cci.fsu.edu/?page_id=393 | Implementing statistical methods for generalizing randomized trial findings to a target population |
ctgate.cci.fsu.edu/?page_id=394 | Applicability of trials in rheumatoid arthritis and osteoarthritis: A systematic review and meta-analysis of trial populations ... |
ctgate.cci.fsu.edu/?page_id=395 | A data-zone scoring system to assess the generalizability of clinical trial results to individual patients. |
ctgate.cci.fsu.edu/?page_id=396 | Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights. |
ctgate.cci.fsu.edu/?page_id=397 | Generalizability of the FOURIER trial to routine clinical care: Do trial participants represent patients in everyday practice? |
ctgate.cci.fsu.edu/?page_id=398 | Diagnostic Assessment of Assumptions for External Validity: An Example Using Data in Metastatic Colorectal Cancer. |
ctgate.cci.fsu.edu/?page_id=399 | Comparison of Methods to Generalize Randomized Clinical Trial Results Without Individual-Level Data for the Target Population. |
ctgate.cci.fsu.edu/?page_id=400 | Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases. |
ctgate.cci.fsu.edu/?page_id=401 | Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics. |
ctgate.cci.fsu.edu/?page_id=402 | Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes popula... |
ctgate.cci.fsu.edu/?page_id=403 | Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Ou... |
ctgate.cci.fsu.edu/?page_id=404 | Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease. |
ctgate.cci.fsu.edu/?page_id=405 | A Standardisation Approach to Compare Treatment Safety and Effectiveness Outcomes between Clinical Trials and Real World Populat... |
ctgate.cci.fsu.edu/?page_id=406 | Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial ... |
Идет сбор информации... Обновить
США - Таллахасси - 128.186.72.242
Florida State University
Florida State University
HTTP/1.1 200 OK
Date: Fri, 03 Jun 2022 14:55:36 GMT
Server: Apache
X-UA-Compatible: IE=edge
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
X-Frame-Options: SAMEORIGIN
Upgrade: h2,h2c
Connection: Upgrade
Vary: Accept-Encoding
X-XSS-Protection: 1; mode=block
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"